This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The move follows the 2019 merger between Caprion and HistoGeneX , a Belgian histopathology and genomics lab. We wanted to create a brand that is unique in the market, relevant to our clients and inspiring to our employees around the world,” said Nick Wright, president and COO of CellCarta, in a statement about the rebrand. “Our
Exact Sciences (Overall Rank 281) Exact Sciences , founded in 1995, is a molecular diagnostics company specializing in early cancer screening and diagnostic tests. Exact Sciences is also investing in its pipeline to develop innovative solutions before, during and after a cancer diagnosis. Thermo Fisher Scientific boasts a $42.86
Approximately 85% of rare diseases are genetic, offering significant opportunities to develop better treatments as our understanding of the human genome improves 1. Concentrating on patient identification early in the clinical phases can drive brand loyalty and develop more effective tactics, to address unmet patient needs.
The San Nicolás site supports Bayer’s global vegetable seeds R&D pipeline for varieties sold to customers in more than 130 countries and territories under the Seminis ® and De Ruiter ® brands, both united under Vegetables by Bayer. “By The Bayer brand stands for trust, reliability and quality throughout the world. billion euros.
Lifescience podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the lifescience industry. The result?
These data reinforce the importance of early comprehensive genomic testing to uncover actionable oncogenic drivers, including NTRK gene fusions, to assist identify patients who are presumably to profit from a targeted treatment approach.”. The Bayer brand stands for trust, reliability and quality throughout the world. billion euros.
About Bayer Bayer is a global enterprise with core competencies in the lifescience fields of health care and nutrition. The Bayer brand stands for trust, reliability and quality throughout the world. The company’s approach to research prioritizes targets and pathways with the potential to impact the way that cancer is treated.
“Our novel AI technology produces a brand new dataset that accurately represents all of the statistical patterns in the underlying health records.
There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent.
rows of data. Lesh MD, founder and CEO of Syntegra.
Marieke Oudelaar (Max Planck Institute for Biophysical Chemistry in Göttingen) for her outstanding contributions in the development of methods to characterize the 3D structure of the genome and her work on the interaction between gene-regulatory elements at specific gene loci. Dr. Connor W. billion euros. billion euros.
The name Zeneca was invented by a branding consultancy who had been instructed to find a name which was memorable, had no associations with other companies, nor was offensive in any language”. The profits from these products funded the development of new drugs, such as gastroesophageal treatment Losec and cardiovascular treatment Aptin.
(NYSE: TMO) today announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable.
million (DKK 585 million) to the Ancient Environmental Genomics Initiative for Sustainability (AEGIS), advancing climate-resilient crops and showcasing its broader commitment to global sustainability. Though the companys sustainable revenue accounts for just 4%, Novo Nordisk actively invests in broader environmental initiatives.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content